The association between periodontitis and the dysbiotic biofilm necessitates that patients maintain excellent oral hygiene. Therefore, step 1 of the UK clinical practice guidelines for the treatment of periodontal diseases is aimed at behaviour change and motivation in successful removal of the supragingival dental biofilm and risk-factor control, which involves all the health behavioural change interventions that mitigate recognized risk factors for periodontitis onset and progression (smoking cessation, diabetes management). Step 1 should be tailored for the patient throughout the treatment journey and jointly with clinical findings and medical history. CPD/Clinical Relevance: Step 1 lays the groundwork when progressing through ensuing steps of treatment and can affect response to any periodontal therapy.
No takes yet. Share an insight, caveat, or question.
Keh et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: